期刊名称：DIABETES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published. |
Instructions to Authors
ABOUT THE JOURNAL
WEB-BASED MANUSCRIPT SUBMISSION
EDITORIAL OFFICE CONTACT INFORMATION
FORMS AND REQUIREMENTS
FINANCIAL OBLIGATIONS
MANUSCRIPT STYLE AND FORMAT
RAPID PUBLICATIONS
BRIEF GENETICS REPORTS
SUBMITTING A MANUSCRIPT (PLEASE READ)
FORMS AND REQUIREMENTS
Diabetes does not publish material that has been reported elsewhere. Prior publication specifically includes symposia, proceedings, preliminary communications, books, and invited articles, unless presented in conjunction with the American Diabetes Association (ADA) Annual Meeting. Standard abstracts for scientific meetings do not preclude publication of the data in Diabetes. Prior publication of any of the data on the Web should be disclosed in the author's comments to the editor in chief upon manuscript submission.
Conflicts of interest or support of private interests must be clearly explained. The ADA duality of interest policy applies to all authors, who must complete and sign the duality of interest disclosure statement, which can be found in every issue of Diabetes.
Work appearing in Diabetes is copyrighted by the American Diabetes Association, Inc. In accord with The Copyright Revision Act of 1976, all submissions must be accompanied by the copyright assignment form signed by all authors. All accepted manuscripts become the permanent property of ADA and may not be published elsewhere without written permission from the ADA. Transfer of copyright to ADA implies transfer of rights for printed, electronic, microfilm, and facsimile publication. Permission requests to reproduce material from Diabetes should be addressed to Permissions Editor, Diabetes, American Diabetes Association, 1701 N. Beauregard St., Alexandria, VA 22311, (fax) 703-683-2890, (e-mail) permissions@diabetes.org.
Diabetes subscribes to the requirements stated in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (N Engl J Med 336:309-315, 1997) that authorship implies substantial contributions to conception and design or analysis and interpretation of data and drafting of the article or critical revision for important intellectual content.
All accepted manuscripts will be edited according to Scientific Style and Format (the Council of Biology Editors style manual; Cambridge, U.K., Cambridge University Press) and The Chicago Manual of Style (The University of Chicago Press, Chicago, IL) by ADA professional publications staff. The authors are responsible for all statements made in their articles or editorials, including any editing changes.
FINANCIAL OBLIGATIONS
Page charges are assessed for regular articles, rapid publications, brief genetics reports, and other unsolicited articles to help defray publication costs. The charge is $85 per journal page. Each color figure printed incurs a charge of $630. Unless otherwise specified, it will be assumed that the corresponding author is responsible for payment.
MANUSCRIPT STYLE AND FORMAT
Original articles and Perspectives must be limited to 4,000 words in the main text plus an additional 200 words in the abstract, no more than 50 references, and a maximum of eight tables and/or figures. Captions to all tables and figures combined should be a maximum of 500 words.
Each figure should be no larger than 1/4 printed page when all parts are combined (see details below). Use of bar graphs is discouraged; tables should be used instead.
The manuscript should be arranged in the following order: title page, abstract, introduction (no heading), research design and methods, results, discussion, acknowledgments, references, tables, and figure legends.
Only manuscripts that meet these requirements will be considered for publication.
Title page. Include title; short running title (limit: 45 characters, including spaces); first name, middle initial, and last name of each author; name and city and state/country locale of departments and institutions with which each author is affiliated (in English); and name, address, telephone number, fax number, and e-mail address (VERY IMPORTANT) of corresponding author.
Abstract . Summarize the content of the paper in 200 words or fewer. The abstract should be self-contained and understandable without reference to the text; it should not contain reference numbers.
Main text . Studies involving experimental animals must state the species, strain, and other pertinent information. When describing surgical procedures, identify the preanesthetic and anesthetic used, and state the amount or concentration and the route and frequency of administration. The use of paralytic agents, e.g., curare or succinylcholine, is not an acceptable substitute for anesthesia. When other invasive procedures are described, report the analgesic or tranquilizing drugs used; if none were used, provide justification for such exclusion.
When reporting studies on human subjects or patients, describe their characteristics. If results of an experimental investigation of humans are reported, state formally that consent was obtained from the subjects after the nature of the procedure was explained. When anesthetized humans are studied, indicate that the procedure was in accord with institutional guidelines. All human investigation must be conducted according to the principles expressed in the Declaration of Helsinki.
All studies involving animals must state that guidelines for the use and care of laboratory animals of the authors' institution or the National Research Council or any national law were followed.
The designations type 1 (insulin-dependent, IDDM) and type 2 (non-insulin-dependent, NIDDM) should be used when referring to the two major forms of diabetes. Diabetic should not be used as a noun.
Statistical methods should be identified.
The generic names of drugs should be used. If a special item is obtained, include supplier, city, and state, or city and country if not in the U.S.
Metric units should be used. Authors must use Système International (SI) units (see table in each issue). Units of measure should be abbreviated (when used with numbers) in accord with the Council of Biology Editors style manual. See the list of abbreviations for those that need not be defined; other abbreviations should be defined on first use.
Acknowledgments. Acknowledgments of assistance and financial support should be stated briefly. Acknowledgments of aid or criticism should be approved by the person whose help is being recognized.
References. The reference list should be limited to no more than 50 references. Number references in order of appearance in text. Do not use the footnote/endnote function found in some word-processing software. Identify a reference number in the text by enclosing it in parentheses. Works submitted for publication cannot be included in the reference section and should be cited as unpublished observations in the text with the initials and last names of all authors. Include all authors (do not use et al. except in text) and complete article titles. Abbreviate names of journals as in Index Medicus; spell out names of unlisted journals. Indicate abstracts and supplements. Supply inclusive page numbers. Authors are responsible for the accuracy of the references. Diabetes is included in the National Library of Medicine's MEDLARS database, BRS Colleague database, Index Medicus, and Current Contents (Basic Science and Clinical Practice).
Examples of references
- Primhak RA, Whincup G, Tsankas JN, Milner RDQ: Reduced vital capacity in insulin-dependent diabetes. Diabetes 36:324-326, 1987
- Nerup J, Christy M, Patz P, Ryder P, Svejgaard A: Aspects of the genetics of insulin-dependent diabetes mellitus. In Immunology in Diabetes.
- Andreani D, Dimario U, Federlin KF, Heding LG, Eds. London, Kimpton, 1984, p. 63-70
- Seine S, Bell GI: Comparison of the 5'-flanking sequences of chimpanzee, African green m, and human insulin genes (Abstract). Diabetes 34 (Suppl. 1):20A, 1985
- Permutt MA, Andreone TA, Chirgwin J, Elbein S, Rotwein P: Insulin gene polymorphism and type II or non-insulin-dependent diabetes mellitus (NIDDM). In Proc Int Congr Endocrinology, 7th ed. Labrie F, Proulx L, Eds. Amsterdam, Excerpta Med., 1985, p. 245-248
- Beta cell function in type 2 diabetes: glucose metabolism and insulin secretion in the normal pancreas [article online], 1999. Available from http://www.amaryl.com/TXT/Clinical_Management/Overview/beta_cell_failure_TXT.html. Accessed 4 May 2000
Tables. Tables should be double spaced on separate pages with table number and title. Tables with internal divisions (Tables 1A and B) should be submitted as individual tables, i.e., Tables 1 and 2. Symbols for units should be confined to column headings. Abbreviations should be kept to a minimum and defined in the table legend. For footnotes, use the following symbols consecutively, left to right, top to bottom of table: *, ? ? ? ||, #, **, ††, etc. (More on Tables below.)
Figures. Figures should be produced at the size they should appear in the printed journal, not to exceed 1/4 page when all parts are combined. Plan the size to fit in 1, 1.5, or 2 columns:
1 column = 27 picas high x 21 picas wide (4.5 x 3.5 in, 11.4 x 8.9 cm)
1.5 columns = 14.5 picas high x 30 picas wide (2.4 x 5 in, 6.1 x 12.7 cm)
2 columns = 14.5 picas high x 43 picas wide (2.4 x 7.1 in, 6.1 x 18 cm)
At 100% size, no lettering should be smaller than 8 point (0.3 cm high) or larger than 12 point (0.4 cm high). Lettering should be bold and solid. Lines should be thick, solid (not gray), and no smaller than 1-point rule.
Information on the axes should be succinct, using abbreviations where possible, and the label on the y-axis should read vertically, not horizontally. Key information should be placed in any available white space within the figure; if space is not available, the information should be placed in the legend. In general, figures with multiple parts should be marked A, B, C, etc., with a description of each panel being placed in the legend rather than on the figure.
Lines in graphs should be bold enough to be easily read after reduction, as should all symbols used in the figure. Data points are best marked with the following symbols, again assuring that they will be readily distinguishable after reduction:  . IMPORTANT NOTE: In the figure LEGEND, please use words rather than the symbols; e.g., "black circles = group 1; white squares = group 2; black bars = blood glucose; white bars = C-peptide." Bars should be black or white only, unless more than two data sets are being presented; further bars should be drawn with clear bold hatch marks or stripes, not shades of gray.
Printing of color figures incurs an additional charge, paid by the author; color figures should not be submitted for reproduction in black and white. The charge for each color figure published is $630.
Authors must be able to provide written permission from the original copyright holder for reproduction of materials (e.g., figures and tables) taken from other sources.
RAPID PUBLICATIONS
Novel findings considered to be of truly outstanding importance that would lose scientific impact if not published promptly should be submitted as rapid publications. These reports should describe a completed, concise, and properly controlled investigation. Manuscripts must be limited to 2,000 words plus a 200-word abstract, a maximum of four tables and/or figures, and no more than 25 references. An editorial decision will be made within 3 weeks after sending the manuscript out for peer review. In some cases, no written review or explanation will be provided. Rejected papers may be resubmitted as regular manuscripts and will be reviewed accordingly. It has been our experience that only very few reports are suitable for publication as "Rapid."
Each rapid publication will be posted on the Diabetes World Wide Web site as soon as possible after the author has approved proofs and before the article is printed in the journal. The date of posting will appear in the printed copy of the article.
BRIEF GENETICS REPORTS
Genetic studies that are relevant to diabetes and diabetic complications and can be presented in a concise format will be considered for publication in the Brief Genetics Reports section. Suitable for presentation in this format are studies identifying new genes and their localization, observations on the molecular nature of allelic variants (normal and pathologic), or linkage and association studies. Brief genetics reports should be written in the following format:
- An abstract of no more than 200 words, containing essential introductory information and a summary of the results. References may not be included.
- The main text of no more than 2,000 words and up to four tables and/or figures.
- References numbering no more than 25. (This format is similar to that for Letters in Nature Genetics.) DNA sequences should be deposited in one of the genetic databases.
Additional data can be prepared in the form of an appendix that will be available from the authors; if the authors wish, such an appendix will be made available on the journal's World Wide Web site.
SUBMITTING A MANUSCRIPT
Diabetes now takes only online manuscript submissions. The submission site can be found at http://diabetes.manuscriptcentral.com. Please read all submission instructions carefully.
When your submission is complete, copyright assignment and duality disclosure forms must be faxed to (215) 382-4285 (new number as of 23 September 2003).
Uploading Your Files Online
After you have read the current instructions for authors, log into the manuscript submission site and go to the Author Center. Once you have entered information about the authors, institutions, title, abstract, keywords, etc., you will arrive at the File Upload Center. In the File Upload Center, you will upload all files associated with your manuscript submission:
- The main text of your article (including the title page, abstract, text, etc.), which will be called the "Main Document."
- Any tables and/or figures that have been saved separately from the main text document.
- Any other files you wish to provide for review, including copies of referenced material or supplemental data.
- If possible, .pdf copies of signed copyright and duality forms.
- Any files you wish to include in an online Appendix.
In the File Upload Center, you will be able to browse your computer for the files associated with your manuscript. When you upload each file, you will be asked to choose a designation from the pull-down menu, to indicate whether the file should be made available for review, and to enter a description of the file (e.g., "main text," "Figure 1," "Table 1," etc.). When you enter a description of a supporting document, please indicate clearly what the document is as well as its format (e.g., "online appendix MS Excel," "in press reference").
Your uploaded files will appear in two columns: "Files for Review" and "Original Files." Files for Review will contain the .pdf or .jpg files created by the system from your word processing or image files as well as any files uploaded in formats that the system cannot convert. Original Files will contain your original word processing and image files. The editorial staff will be able to release these files for review if necessary and, if your manuscript is accepted, will use these original files for production whenever possible; therefore, it is very important that you not delete your original files.
Text. The online submission system will accept manuscript files in a variety of formats. The text of your manuscript should be prepared using a word processing program and saved as a .doc, .rtf, .ps, or .pdf file. (NOTE: If you use Word Perfect to prepare your text, you must save your file as .doc or .rtf.) The system will convert any files uploaded as .doc, .rtf, or .ps to .pdf files for review and will retain your original files so that they will be accessible for production.
Please note the following regarding text files:
- If you upload a .pdf file rather than a word processing file and your manuscript is accepted, you will be asked to provide a word processing file of the final manuscript for production. Failure to provide such a file promptly may result in publication delays.
- If the change-tracking function of a word processing program is used to track additions and deletions to the original manuscript, make sure that all changes are "accepted" in the electronic version you submit. You must "turn off" the change-tracking function before you submit the manuscript. Failure to do so may result in publication delays if your manuscript is accepted.
- Do not use the footnote/endnote functions found in some word processing software. Instead, reference numbers in the text should be in normal type in parentheses in the style set forth in the journal. Failure to follow this instruction may result in publication delays if your manuscript is accepted.
- Although you may insert your tables and figures into your text document, you will probably be asked to provide separate electronic and/or hard copies for production if your manuscript is accepted. Also, please check your .pdf proof carefully to make sure that the tables or figures inserted in the text are readable. See more notes on tables and figures below.
Tables. If you include tables in your main text file, as suggested, please place them at the end of the manuscript. In MS Word or Word Perfect, please create tables using the "Insert Table" command. In Word, this appears under the "Table" menu. In Word Perfect, this appears under the "Insert" menu. Tables can also be created in MS Excel and cut and pasted into MS Word. Tables should be one to a page. When creating tables, please use a 10-point font. Do not use a smaller font because the table may not be readable once the document is uploaded into the submission system. IMPORTANT: Do not use tabs or spaces in text to make data look like a table.
Although you may use the "landscape" feature for tables, if necessary, for print purposes it is requested that you use "portrait" when possible. HOWEVER, if you do have a landscape table that cannot be arranged as a portrait, you should save it as a separate file rather than including it in your text file in order to ensure that it is readable for the editors and reviewers.
Tables created using word processing software and saved as .doc or .rtf files will be converted to .pdf files for review purposes ONLY. Note that if you are not satisfied with the readability of the .pdf file of your table, you can release the word processing file (.doc or .rtf) of your table for review by moving it from the "Original Files" column into the "Files for Review" column. You may also submit tables created in MS Excel or tables saved as images (.jpg, .gif, .tif, .eps). However, tables submitted as images cannot be used for print purposes, only for the review process. If you have only submitted tables as images, you WILL be requested to resubmit them in .doc, .txt., or .rtf format in order to prepare them for print.
Figures/images. You may save images as part of your text file; however, if you choose to do so, please place them at the end of the manuscript, after the tables. Figures may also be submitted as separate files, which may provide more readable images for review. File names should clearly identify the figures (e.g., figure1.jpg). The manuscript submission system supports many of the most popular file formats, including .jpg, .gif, .tif, and .eps, all of which will be converted into smaller .jpg images for review. NOTE: These small .jpg files cannot be used for print production; they are for review purposes only. Again, if you find that the smaller .jpg made available in the Files for Review column is not readable, you may release the original file by moving it into the Files for Review column in the File Upload Center.
Please do not submit figures in Excel formats. Excel charts can be copied and pasted into word processing programs. Figures submitted as .pdf files produce the best results. (Note: Large images should be converted to .pdf, .jpg, or .gif formats, which use compression to create smaller files.) IMPORTANT: If some but not all figures are revised during the review process, be sure to upload an entire new set of figures rather than only those that were revised.
Note that the image submitted for review need not be at the high resolution necessary for print (600 dpi); for review purposes, a resolution of 300 dpi may be acceptable and will upload more quickly into the system. However, please be aware that an editor may ask you to provide a high-resolution electronic file or hard copy to check a critical image if necessary. If your article is accepted and you have not provided .pdf files of all figures, you will be asked to provide either .pdf files via web/e-mail or two clearly printed hard copies of each figure via mail. Electronic files other than .pdf are not suitable for production at this time.
More tips
- Use simple filenames when saving your documents, and do not use special characters such as [brackets], (parentheses), punctuation marks (?, !, .), and symbols (e.g., @, #, &, $, %).
- Avoid spaces in your filenames: for example, instead of "Figure 1.gif," use "Figure1.gif."
- Macintosh users, please see additional guidelines and tips by clicking on the "Submitting Manuscripts" icon on the "Instructions and Forms" page, which you can reach by clicking the icon on the login page of the submission site.
Checking your files for review (proofs) before submission
Once you have uploaded your text and image files, you will be given an opportunity to see the manuscript and images as the editors and reviewers will see them. Please check these files (proofs) carefully for special characters and to make sure your tables and figures reproduce legibly. Do not click on "Submit Manuscript" until you are satisfied with the quality of the proofs. If you are having trouble uploading files, please click on the Help button in the top right corner of the manuscript submission screen or contact the editorial office.
NOTE: Your manuscript will not be assigned an official submission date until staff have determined that the manuscript submission is complete, tables and figures are readable and suitable for review, and copyright and duality forms signed by all authors (and duality disclosure statements if applicable) have been received.
SUBMISSION OF SUPPLEMENTS
A proposal for a supplement must first be submitted to ADA. The proposal must specify:
- The name of the pharmaceutical firm sponsoring the supplement (not merely the name of the public relations agency handling its publication).
- If the supplement is based on a symposium, indicate where and when the symposium was held and how the speakers and papers were selected.
- Whether authors will be paid and, if so, how much.
If the proposal is approved, it will be forwarded to the editor of Diabetes. Initial approval by ADA does not commit an editor to accept a proposal in whole or in part. All manuscripts are subject to the same peer review as other manuscripts in the journal.
Editorial Board
Editor in Chief
Franz M. Matschinsky, MD
Associate Editors
Gerard T. Berry, MD
Morris J. Birnbaum, MD, PhD
Guenther Boden, MD
Barry J. Goldstein, MD, PhD
Mitchell A. Lazar, MD, PhD
Ali Naji, MD, PhD
Stephen S. Rich, PhD
Charles A. Stanley, MD
Bryan A. Wolf, MD, PhD
Fuad N. Ziyadeh, MD
Editorial Board
Rexford S. Ahima, MD, PhD
Alan D. Attie, PhD
Nir Barzilai, MD
Susan Bonner-Weir, PhD
Donald W. Bowden, PhD
Patrick M. Catalano, MD, FACOG
Patrick J. Concannon, PhD
Silvia Corvera, MD
Joel Keith Elmquist, DVM, PhD
Thomas W. Gardner, MD, MS
W. Timothy Garvey, MD
Stanley Goldfarb, MD, FACP
Laurie J. Goodyear, PhD
Steven M. Haffner, MD
Alberto Hayek, MD
Morey W. Haymond, MD
Jean-Claude Henquin, MD
Takashi Kadowaki, MD, PhD
Masato Kasuga, MD
Mark McCarthy, MD, FRCP
Michael L. McDaniel, PhD
M. Alan Permutt, MD
Mark Prentki, MSc, PhD
Camillo Ricordi, MD
Robert A. Rizza, MD
Luciano Rossetti, MD
Aldo Rossini, MD
Elizabeth Seaquist, MD
Kumar Sharma, MD
Alan R. Shuldiner, MD
Michael W. Stumvoll, MD
Stephen C. Woods, PhD
Mark A. Yorek, PhD
Correspondence concerning the copyediting of accepted manuscripts should be addressed to:
Joseph Sheffer, Assistant Managing Editor, Diabetes
American Diabetes Association
1701 N. Beauregard St.
Alexandria, VA 22311
tel.: (703) 299-2083
fax: (703) 683-2890
e-mail: jsheffer@diabetes.org
Correspondence concerning the production process of accepted manuscripts should be addressed to:
Heather Norton, Production Manager, Diabetes
American Diabetes Association
1701 N. Beauregard St.
Alexandria, VA 22311
tel.: (703) 299-2042
fax: (703) 683-2890
e-mail: hnorton@diabetes.org
The editorial office can be reached at
Phone: (215) 382-4282 (new number as of 4 August 2003)
Fax: (215) 382-4285 (new number as of 23 September 2003)
E-mail: diabetes@mail.med.upenn.edu.
|
刊名字顺( Alphabetical List of Journals):
返回页首 
